Jacobs Levy Equity Management, Inc Rvl Pharmaceuticals PLC Transaction History

Jacobs Levy Equity Management, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.79 - $4.19 $946,169 - $1.42 Million	-339,129 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.8 - $3.78 $194,569 - $262,668	-69,489 Reduced 17.01%	339,129 $1.02 Million
Q1 2021 May 17, 2021	BUY	$3.26 - $4.84 $1.33 Million - $1.98 Million	408,618 New	408,618 $1.33 Million
Q3 2020 Nov 16, 2020	SELL	$4.82 - $8.77 $68,685 - $124,972	-14,250 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$2.83 - $6.99 $220,499 - $544,625	-77,915 Reduced 84.54%	14,250 $96,000
Q1 2020 May 15, 2020	BUY	$3.18 - $7.0 $33,708 - $74,200	10,600 Added 13.0%	92,165 $293,000
Q4 2019 Feb 14, 2020	BUY	$3.46 - $7.7 $197,617 - $439,785	57,115 Added 233.6%	81,565 $570,000
Q3 2019 Nov 14, 2019	SELL	$2.8 - $3.99 $35,977 - $51,267	-12,849 Reduced 34.45%	24,450 $94,000
Q2 2019 Aug 13, 2019	BUY	$2.34 - $4.28 $87,279 - $159,639	37,299 New	37,299 $142,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.